Voranigo 40 mg (Vorasidenib Tablet) 40mg

VORANIGO 40 MG (vorasidenib) is a prescription tablet used for certain brain tumors. This oral medication helps manage tumor growth in adults with specific low-grade gliomas. Store at room temperature and keep out of reach of children.

Strength

40mg

Pack Size

30s

Storage

15-25°

Manufacturer / TM Owner

SERVIER PHARMACEUTICALS LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

VORANIGO 40 MG (vorasidenib) is prescribed to treat adults with certain types of low-grade gliomas, a type of brain tumor. It is used for tumors with specific genetic mutations like IDH1 or IDH2. This medication helps slow tumor growth rather than cure the condition. Patients should discuss suitability with their healthcare provider.

Side Effects

VORANIGO 40 MG (vorasidenib) works by targeting pathways involved in tumor cell growth. Common effects include mild nausea, fatigue, or changes in liver function tests. Some patients may experience digestive discomfort or skin sensitivity. Effects vary by individual and should be monitored by a medical professional.

Precautions & Warnings

Keep VORANIGO 40 MG (vorasidenib) in its original packaging at room temperature (15–25°C). Avoid exposure to moisture or direct sunlight. Do not crush, split, or chew the tablets. Use only as directed by a healthcare provider. Keep out of reach of children and pets.

Avoid Interactions

VORANIGO 40 MG (vorasidenib) may interact with other medications, including certain antibiotics, antifungals, or herbal supplements. Avoid grapefruit products as they can affect how the drug is processed. Alcohol use should be discussed with a doctor. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

VORANIGO 40 MG (vorasidenib) is used to treat adults with certain low-grade brain tumors, specifically those with IDH1 or IDH2 mutations.

Store VORANIGO 40 MG at room temperature (15–25°C) in its original packaging, away from moisture and sunlight.

VORANIGO 40 MG may interact with other drugs; consult your healthcare provider before combining medications.

Common effects may include nausea, fatigue, or changes in liver function tests. Report any persistent issues to your doctor.

VORANIGO 40 MG helps slow tumor growth but is not a cure. It should be used under medical supervision.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.